Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
YARW

Market Cap: $523.62K

YI

Yarrow Bioscience Inc

YARW

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin98.68%

EBITDA Margin-47.78%

EBIT Margin-47.83%

Pre-tax Margin-47.83%

Net Profit Margin-47.26%

Earnings Yield-41.19%

Valuation Multiples

Price / Book0.02

Price / Sales1.15

Price / Earnings-0.03

PEG-0.00

Forward PEG-0.00

EV / Sales-53.10

EV / EBITDA1.11

EV / Operating Cash Flow0.94

EV / Free Cash Flow0.94

Price / Free Cash Flow-0.02

Price / Operating Cash Flow-0.02

Cash Flow & Capital

Free Cash Flow / Share-$1,504.88

Operating Cash Flow / Share-$1,504.88

Free Cash Flow Yield-49.17%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue4.45%

Dividend Payout Ratio0.00%

Dividend Yield1.32%

Liquidity & Leverage

Current Ratio20.86

Quick Ratio20.86

Cash Ratio19.93

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA1.14

Solvency Ratio-17.34

Financial Leverage1.05

Efficiency & Working Capital

Asset Turnover0.02

Fixed Asset Turnover5.40

Inventory Turnover0.00

Receivables Turnover0.00

Payables Turnover0.02

Days Sales Outstanding0

Days Inventory Outstanding0

Days Payables Outstanding15,877.5

Operating Cycle0

Cash Conversion Cycle-15,877.5

Working Capital Turnover0.02

Returns & Quality

Return on Equity-69.57%

Return on Assets-82.93%

Return on Invested Capital-98.91%

ROCE-98.91%

Return on Tangible Assets-82.93%

Operating Return on Assets-86.98%

Income Quality1.20

Tax Burden0.99

Interest Burden1.00

Balance Sheet & Intrinsic Metrics

Enterprise Value$-24.11M

Invested Capital$24.64M

Working Capital$24.55M

Tangible Asset Value$24.64M

Net Current Asset Value$24.55M

Graham Net-Net$1,384.93

Book Value / Share$1,440.17

Tangible Book Value / Share$1,440.17

Cash / Share$1,457.18

Financial Health Scores

Piotroski Score2

Altman Z-Score-31.10

Revenue$454K

EBIT$-21.71M

Market Cap$24.12M

Working Capital$24.55M

Retained Earnings$-761.24M

Total Assets$25.87M

Total Liabilities$1.24M